Development of 1‐(2‐aminophenyl)pyrrole‐based amides acting as human topoisomerase I inhibitors
Archiv der Pharmazie · 2023
DOI: 10.1002/ardp.202300270 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2023. Verfasst von Gabriele Carullo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Siena, Italy. Hauptthemen laut MEDLINE: Pyrroles, Amides, Topoisomerase I Inhibitors, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: None..
Abstract (Originalsprache)
Topoisomerases are ubiquitous enzymes in the human body, particularly involved in cancer development and progression. Topoisomerase I (topoI) performs DNA relaxation reactions by “controlled rotation” rather than by “strand passage.” The inhibition of topoI has become a useful strategy to control cancer cell proliferation. Nowadays, different compounds have undergone clinical trials, but the search for new molecular entities is necessary and benefits from medicinal chemistry efforts. Pyrrole‐based compounds emerged as promising antiproliferative agents, with particular interest in breast cancer therapy and topoI inhibition. Starting from these observations and based on the scaffold‐hopping approach, we developed a small library of 1‐(2‐aminophenyl)pyrrole‐based amides ( 7a–f ) as new anticancer agents. Tested on a panel of cancer cell lines, 7a–f displayed the most interesting profile in MDA‐MB‐231 cells, where the most active compounds, 7d–f , were able to induce death by apoptosis. Direct enzymatic assays and docking simulations on the topoI active site (PDB: 1A35) revealed the inhibitory activity and potential binding site for the newly developed 1‐(2‐aminophenyl)pyrrole‐based amides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dipartimento di Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Siena, Italy.
- Dipartimento di Chimica, Università degli Studi di Milano, Milano, Italy.
- Dipartimento di Farmacia e Scienze della Salute e della Nutrizione, Università della Calabria, Rende, Italy.
- Dipartimento di Farmacia, Università degli Studi di Salerno, Fisciano, Italy.
- Unità di Proteomica e Spettrometria di Massa, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
ORCID-Profile: Gabriele Carullo, Sarah Mazzotta, Giuseppe Campiani
Förderung
- None.
Zitieren
APA
Carullo, G., Mazzotta, S., Ceramella, J., Iacopetta, D., Ramunno, A., Rosano, C., Brizzi, A., Campiani, G., Aiello, F., & Sinicropi, M. S. (2023). Development of 1‐(2‐aminophenyl)pyrrole‐based amides acting as human topoisomerase I inhibitors. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202300270
Vancouver
Carullo G, Mazzotta S, Ceramella J, Iacopetta D, Ramunno A, Rosano C, et al. Development of 1‐(2‐aminophenyl)pyrrole‐based amides acting as human topoisomerase I inhibitors. Archiv der Pharmazie. 2023. doi:10.1002/ardp.202300270
BibTeX
@article{Carullo2023,
author = {Carullo, Gabriele and Mazzotta, Sarah and Ceramella, Jessica and Iacopetta, Domenico and Ramunno, Anna and Rosano, Camillo and Brizzi, Antonella and Campiani, Giuseppe and Aiello, Francesca and Sinicropi, Maria S},
title = {Development of 1‐(2‐aminophenyl)pyrrole‐based amides acting as human topoisomerase I inhibitors},
journal = {Archiv der Pharmazie},
year = {2023},
doi = {10.1002/ardp.202300270}
}
EUVIMED